Close Menu

NEW YORK (360Dx) — French diagnostic and theranostics firm Theradiag on Wednesday reported a 9 percent decline in revenues for the first half of 2018 amid lower sales from its theranostics operations.

In its interim results for the six-month period ended June 30, Theradiag said its revenues fell to €4.6 million ($5.4 million) from €5.0 million in the same period of 2017. The company attributed the drop to non-recurring theranostics revenue from pharmaceutical partners in H1 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.